Rifaximin Treatment in Bloating Predominant Functional Bowel Disorders
Rifaximin Treatment in Bloating Predominant Functional Bowel Disorders
Not yet recruiting · NCT07522255 · Registry updated 2026-04-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Rifaximin Treatment in Bloating Predominant Functional Bowel Disorders | Digestive System Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, colonic disorder, constipation disorder, digestive system disorder, functional colonic disease, intestinal disorder, irritable bowel syndrome | Not yet recruiting | Phase 3 | 2026-04-13 | NCT07522255 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mahidol University | 107 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Faculty of Medicine Siriraj Hospital, Mahidol University | Bangkok Noi | Thailand | 6 |